• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌筛查过度使用和不足:患者和医生因素。

Cervical cancer screening overuse and underuse: patient and physician factors.

机构信息

605 W Santa Ana Blvd, Bldg 28, Ste 639, Santa Ana, CA 92701, USA.

出版信息

Am J Manag Care. 2013 Jun;19(6):482-9.

PMID:23844709
Abstract

OBJECTIVES

Despite recommendations for triennial cervical cancer screening for low-risk women 30 years and older, annual screening remains common. We studied how often women receiving care from an academically affiliated medical group were screened, and patient and provider factors associated with overuse and underuse. We also explored the impact of changing measurement intervals on computed screening frequency.

DESIGN

The study included women 30 years and older continuously enrolled over a 3-year period and excluded women with history of abnormal screening and conditions of high risk for cervical cancer.

METHODS

Administrative and laboratory data were merged to link Papanicolaou (pap) test results with patient and ordering provider characteristics. We used logistic regression to analyze multivariate models for overuse and underuse, and modified measurement intervals to test sensitivity to early and late pap smears.

RESULTS

The 8018 women had a mean age of 48years and 95% had an ambulatory physician visit during the observation period. Thirty-four percent of women received guideline-based screening, 45% had overuse, and 21% had underuse. Factors independently associated with overuse included younger age, more medical visits, contraceptive management visits, and gynecology provider specialty. Underuse was associated with older age, fewer medical visits, and increased comorbidity.Overuse was 47% if unsatisfactory paps were not considered and was reduced to 35% if the observation interval was reduced from 36 to 30 months.

CONCLUSIONS

Overuse and underuse of cervical cancer screening are common and clinician and patient factors are identifiable to target quality improvement interventions. Modifying the measurement interval may improve the measure.

摘要

目的

尽管建议低危 30 岁及以上女性每 3 年进行一次宫颈癌筛查,但仍普遍进行年度筛查。我们研究了从学术附属医疗集团接受护理的女性接受筛查的频率,以及与过度使用和使用不足相关的患者和提供者因素。我们还探讨了改变测量间隔对计算筛查频率的影响。

设计

该研究包括连续 3 年入组的 30 岁及以上的女性,并排除了有异常筛查史和宫颈癌高危因素的女性。

方法

行政和实验室数据被合并,将巴氏涂片(pap)检测结果与患者和开单医生的特征联系起来。我们使用逻辑回归分析了过度使用和使用不足的多变量模型,并修改了测量间隔,以测试对早期和晚期巴氏涂片的敏感性。

结果

8018 名女性的平均年龄为 48 岁,95%在观察期内有门诊就诊。34%的女性接受了基于指南的筛查,45%的女性过度使用,21%的女性使用不足。与过度使用独立相关的因素包括年龄较小、就诊次数较多、避孕管理就诊次数较多以及妇科医生的专业。年龄较大、就诊次数较少和合并症增多与使用不足有关。如果不考虑不满意的巴氏涂片,则过度使用的比例为 47%,如果将观察间隔从 36 个月缩短至 30 个月,则过度使用的比例降至 35%。

结论

宫颈癌筛查的过度使用和使用不足很常见,医生和患者的因素可以确定以针对质量改进干预措施。修改测量间隔可能会改善该措施。

相似文献

1
Cervical cancer screening overuse and underuse: patient and physician factors.宫颈癌筛查过度使用和不足:患者和医生因素。
Am J Manag Care. 2013 Jun;19(6):482-9.
2
Physician recommendation for papanicolaou testing among U.S. women, 2000.2000年美国女性巴氏涂片检查的医生建议
Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1143-8. doi: 10.1158/1055-9965.EPI-04-0559.
3
Ambulatory care visits for Pap tests, abnormal Pap test results, and cervical cancer procedures in the United States.美国的巴氏试验、巴氏试验异常结果和宫颈癌手术的门诊就诊情况。
Am J Manag Care. 2010 Jun 1;16(6):e137-44.
4
Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007.基层医疗医生关于巴氏试验筛查实践报告中的专业差异:2006年至2007年全国调查
Ann Intern Med. 2009 Nov 3;151(9):602-11. doi: 10.7326/0003-4819-151-9-200911030-00005.
5
Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.美国疾病控制与预防中心的报告。通过国家乳腺癌和宫颈癌早期检测项目为低收入女性提供服务的医生所采用的巴氏试验间隔时间。
J Womens Health (Larchmt). 2005 Oct;14(8):670-8. doi: 10.1089/jwh.2005.14.670.
6
Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.宫颈癌防治面临的挑战:对美国妇产科医生的调查。
Am J Prev Med. 2013 Aug;45(2):175-81. doi: 10.1016/j.amepre.2013.03.019.
7
Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?人乳头瘤病毒检测联合巴氏试验与单独巴氏试验用于宫颈癌筛查:医生推荐的筛查间隔是多久?
Arch Intern Med. 2010 Jun 14;170(11):977-85. doi: 10.1001/archinternmed.2010.134.
8
Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals.好事过了头?医生的做法和患者对减少巴氏涂片检查间隔频率的意愿。
Med Care. 2010 Mar;48(3):249-59. doi: 10.1097/MLR.0b013e3181ca4015.
9
Factors associated with the overuse or underuse of health care services among medical aid beneficiaries in Korea.韩国医疗救助受益人群中与医疗服务过度使用或使用不足相关的因素。
J Community Health Nurs. 2011 Oct;28(4):190-203. doi: 10.1080/07370016.2011.614837.
10
Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.享有全面医疗保健服务的女性中的宫颈癌:筛查过程中的归因因素
J Natl Cancer Inst. 2005 May 4;97(9):675-83. doi: 10.1093/jnci/dji115.

引用本文的文献

1
Adherence to cervical cancer screening in France: factors influencing the healthcare professionals' decisions-a qualitative study.法国宫颈癌筛查的依从性:影响医疗保健专业人员决策的因素——一项定性研究。
BMJ Open. 2024 Nov 20;14(11):e084795. doi: 10.1136/bmjopen-2024-084795.
2
Non-use and inadequate use of cervical cancer screening among a representative sample of women in the United States.美国代表性女性样本中宫颈癌筛查的未使用和使用不足。
Front Public Health. 2024 Apr 22;12:1321253. doi: 10.3389/fpubh.2024.1321253. eCollection 2024.
3
Examining the association of clinician characteristics with perceived changes in cervical cancer screening and colposcopy practice during the COVID-19 pandemic: a mixed methods assessment.
考察临床医生特征与 COVID-19 大流行期间宫颈癌筛查和阴道镜检查实践感知变化之间的关联:一项混合方法评估。
Elife. 2023 Sep 1;12:e85682. doi: 10.7554/eLife.85682.
4
Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014.美国 2013-2014 年一般风险女性中过度使用宫颈癌筛查检测的情况。
JAMA Netw Open. 2021 Apr 1;4(4):e218373. doi: 10.1001/jamanetworkopen.2021.8373.
5
Effect of an Electronic Health Record Decision Support Alert to Decrease Excess Cervical Cancer Screening.电子健康记录决策支持警报对减少过度宫颈癌筛查的影响。
J Low Genit Tract Dis. 2019 Oct;23(4):253-258. doi: 10.1097/LGT.0000000000000484.
6
Shared Decision-Making and Women's Adherence to Breast and Cervical Cancer Screenings.共享决策与女性对乳腺癌和宫颈癌筛查的依从性。
Int J Environ Res Public Health. 2018 Jul 17;15(7):1509. doi: 10.3390/ijerph15071509.
7
The education gradient in cancer screening participation: a consistent phenomenon across Europe?癌症筛查参与的教育梯度:欧洲普遍存在的现象?
Int J Public Health. 2018 Jan;63(1):93-103. doi: 10.1007/s00038-017-1045-7. Epub 2017 Oct 23.
8
Overtreatment in the United States.美国的过度治疗。
PLoS One. 2017 Sep 6;12(9):e0181970. doi: 10.1371/journal.pone.0181970. eCollection 2017.
9
Cervical Cancer Screening and Prevention in 78 Sexually Transmitted Disease Clinics-United States, 2014-2015.78 家性传播疾病诊所中的宫颈癌筛查和预防-美国,2014-2015 年。
Sex Transm Dis. 2017 Oct;44(10):637-641. doi: 10.1097/OLQ.0000000000000659.
10
Comparative effectiveness of two outreach strategies for cervical cancer screening.两种宫颈癌筛查外展策略的比较效果
Prev Med. 2016 May;86:19-27. doi: 10.1016/j.ypmed.2016.01.016. Epub 2016 Jan 25.